Markers of cerebral damage during delirium in elderly patients with hip fracture

Barbara C van Munster, Catharina M Korse, Sophia E de Rooij, Johannes M Bonfrer, Aeilko H Zwinderman, Johanna C Korevaar, Barbara C van Munster, Catharina M Korse, Sophia E de Rooij, Johannes M Bonfrer, Aeilko H Zwinderman, Johanna C Korevaar

Abstract

Background: S100B protein and Neuron Specific Enolase (NSE) can increase due to brain cell damage and/or increased permeability of the blood-brain-barrier. Elevation of these proteins has been shown after various neurological diseases with cognitive dysfunction. Delirium is characterized by temporal cognitive deficits and is an important risk factor for dementia. The aim of this study was to compare the level of S100B and NSE of patients before, during and after delirium with patients without delirium and investigate the possible associations with different subtypes of delirium.

Methods: The study population were patients aged 65 years or more acutely admitted after hip fracture. Delirium was diagnosed by the Confusion Assessment Method and the subtype by Delirium Symptom interview. In maximal four serum samples per patient S100B and NSE levels were determined by electrochemiluminescence immunoassay.

Results: Of 120 included patients with mean age 83.9 years, 62 experienced delirium. Delirious patients had more frequently pre-existing cognitive impairment (67% vs. 18%, p < 0.001). Comparing the first samples during delirium to samples of non-delirious patients, a difference was observed in S100B (median 0.16 versus 0.10 microg/L, p = < 0.001), but not in NSE (median 11.7 versus 11.7 ng/L, p = 0.97). Delirious state (before, during, after) (p < 0.001), day of blood withdrawal (p < 0.001), pre- or postoperative status (p = 0.001) and type of fracture (p = 0.036) were all associated with S100B level. The highest S100B levels were found 'during' delirium. S100B levels 'before' and 'after' delirium were still higher than those from 'non-delirious' patients. No significant difference in S100B (p = 0.43) or NSE levels (p = 0.41) was seen between the hyperactive, hypoactive and mixed subtype of delirium.

Conclusion: Delirium was associated with increased level of S100B which could indicate cerebral damage either due to delirium or leading to delirium. The possible association between higher levels of S100B during delirium and the higher risk of developing dementia after delirium is an interesting field for future research. More studies are needed to elucidate the role of S100B proteins in the pathophysiological pathway leading to delirium and to investigate its possibility as biomarker for delirium.

Figures

Figure 1
Figure 1
Three representative patients with an intertrochanteric fracture to show the changes of S100B during admission calculated with values of the mixed model analysis of all samples. The final model included delirious state (p < 0.001), day of blood withdrawal (p < 0.001), pre- or postoperative status (p = 0.001) and type of fracture (p = 0.036). Postoperative day 0 is day of surgery.

References

    1. Bitsch M, Foss N, Kristensen B, Kehlet H. Pathogenesis of and management strategies for postoperative delirium after hip fracture: a review. Acta Orthop Scand. 2004;75:378–389.
    1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM IV-TR Washington, DC. 2000.
    1. de Rooij SE, Schuurmans MJ, Mast RC van der, Levi M. Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. Int J Geriatr Psychiatry. 2005;20:609–615. doi: 10.1002/gps.1343.
    1. Meagher DJ, Trzepacz PT. Motoric subtypes of delirium. Semin Clin Neuropsychiatry. 2000;5:75–85.
    1. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C. Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses. J Psychosom Res. 2008;65:229–238. doi: 10.1016/j.jpsychores.2008.05.019.
    1. van Munster BC, Korevaar JC, Zwinderman AH, Levi M, Wiersinga WJ, de Rooij SE. Time-Course of Cytokines During Delirium in Elderly Patients with Hip Fractures. J Am Geriatr Soc. 2008;56:1704–1709. doi: 10.1111/j.1532-5415.2008.01851.x.
    1. Eikelenboom P, Hoogendijk WJ. Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms? Dement Geriatr Cogn Disord. 1999;10:319–324. doi: 10.1159/000017162.
    1. Lundstrom M, Edlund A, Bucht G, Karlsson S, Gustafson Y. Dementia after delirium in patients with femoral neck fractures. J Am Geriatr Soc. 2003;51:1002–1006. doi: 10.1046/j.1365-2389.2003.51315.x.
    1. Barak M, Kabha M, Norman D, Soudry M, Kats Y, Milo S. Cerebral microemboli during hip fracture fixation: a prospective study. Anesth Analg. 2008;107:221–225. doi: 10.1213/ane.0b013e3181770abb.
    1. Edlund A, Lundstrom M, Brannstrom B, Bucht G, Gustafson Y. Delirium before and after operation for femoral neck fracture. J Am Geriatr Soc. 2001;49:1335–1340. doi: 10.1046/j.1532-5415.2001.49261.x.
    1. Goncalves CA, Leite MC, Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem. 2008;41:755–763. doi: 10.1016/j.clinbiochem.2008.04.003.
    1. Basile AM, Fusi C, Conti AA, Paniccia R, Trefoloni G, Pracucci G, et al. S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol. 2001;45:151–159. doi: 10.1159/000052114.
    1. Rasmussen LS, Christiansen M, Rasmussen H, Kristensen PA, Moller JT. Do blood concentrations of neurone specific enolase and S-100 beta protein reflect cognitive dysfunction after abdominal surgery?ISPOCD Group. Br J Anaesth. 2000;84:242–244.
    1. Herrmann M, Ebert AD, Galazky I, Wunderlich MT, Kunz WS, Huth C. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke. 2000;31:645–650.
    1. Pfister D, Siegemund M, ll-Kuster S, Smielewski P, Ruegg S, Strebel SP, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care. 2008;12:R63. doi: 10.1186/cc6891.
    1. Hemmingsen R, Kramp P, Dissing J. Delirium tremens: some clinico-chemical features. A study of alanine-aminotransferase, alcaline phosphatase, prothrombine and enolase. Acta Psychiatr Scand. 1980;62:503–510. doi: 10.1111/j.1600-0447.1980.tb00639.x.
    1. Rasmussen LS, Christiansen M, Hansen PB, Moller JT. Do blood levels of neuron-specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass? Acta Anaesthesiol Scand. 1999;43:495–500. doi: 10.1034/j.1399-6576.1999.430502.x.
    1. Linstedt U, Meyer O, Kropp P, Berkau A, Tapp E, Zenz M. Serum concentration of S-100 protein in assessment of cognitive dysfunction after general anesthesia in different types of surgery. Acta Anaesthesiol Scand. 2002;46:384–389. doi: 10.1034/j.1399-6576.2002.460409.x.
    1. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–948.
    1. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA. The Delirium Observation Screening Scale: a screening instrument for delirium. Res Theory Nurs Pract. 2003;17:31–50. doi: 10.1891/rtnp.17.1.31.53169.
    1. Liptzin B, Levkoff SE. An empirical study of delirium subtypes. Br J Psychiatry. 1992;161:843–845. doi: 10.1192/bjp.161.6.843.
    1. de Rooij SE, van Munster BC, Korevaar JC, Casteelen G, Schuurmans MJ, Mast RC van der, et al. Delirium subtype identification and the validation of the Delirium Rating Scale – Revised-98 (Dutch version) in hospitalized elderly patients. Int J Geriatr Psychiatry. 2006;21:876–882. doi: 10.1002/gps.1577.
    1. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988;23:89–97. doi: 10.1016/0165-1781(88)90037-6.
    1. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24:145–153.
    1. de Jonghe JF. Differentiating between demented and psychiatric patients with the Dutch version of the IQCODE. Int J Geriatr Psychiatry. 1997;12:462–465. doi: 10.1002/(SICI)1099-1166(199704)12:4<462::AID-GPS510>;2-Q.
    1. Weinberger M, Samsa GP, Schmader K, Greenberg SM, Carr DB, Wildman DS. Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc. 1992;40:585–588.
    1. Smit LH, Korse CM, Bonfrer JM. Comparison of four different assays for determination of serum S-100B. Int J Biol Markers. 2005;20:34–42.
    1. Muley T, Ebert W, Stieber P, Raith H, Holdenrieder S, Nagel D, et al. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay. Clin Chem Lab Med. 2003;41:95–103. doi: 10.1515/CCLM.2003.017.
    1. Bruce AJ, Ritchie CW, Blizard R, Lai R, Raven P. The incidence of delirium associated with orthopedic surgery: a meta-analytic review. Int Psychogeriatr. 2007;19:197–214. doi: 10.1017/S104161020600425X.
    1. Dasgupta M, Dumbrell AC. Preoperative risk assessment for delirium after noncardiac surgery: a systematic review. J Am Geriatr Soc. 2006;54:1578–1589. doi: 10.1111/j.1532-5415.2006.00893.x.
    1. Linstedt U, Kropp P, Moller C, Zenz M. [Diagnostic value of s-100 protein and neuron-specific enolase as serum markers for cerebral deficiency after general anesthesia. Study in patient with hip or knee replacement] Anaesthesist. 2000;49:887–892. doi: 10.1007/s001010070042.
    1. Santana SF, Wahlund LO, Varli F, Tadeu VI, Eriksdotter JM. Incidence, clinical features and subtypes of delirium in elderly patients treated for hip fractures. Dement Geriatr Cogn Disord. 2005;20:231–237. doi: 10.1159/000087311.
    1. Casmiro M, Maitan S, De PF, Cova V, Scarpa E, Vignatelli L. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Eur J Neurol. 2005;12:369–374. doi: 10.1111/j.1468-1331.2004.01021.x.
    1. Jonsson H, Johnsson P, Backstrom M, Alling C, utovic-Bergh C, Blomquist S. Controversial significance of early S100B levels after cardiac surgery. BMC Neurol. 2004;4:24. doi: 10.1186/1471-2377-4-24.
    1. Rudolph JL, Marcantonio ER, Culley DJ, Silverstein JH, Rasmussen LS, Crosby GJ, et al. Delirium is associated with early postoperative cognitive dysfunction. Anaesthesia. 2008;63:941–947. doi: 10.1111/j.1365-2044.2008.05523.x.
    1. Stroick M, Fatar M, Ragoschke-Schumm A, Fassbender K, Bertsch T, Hennerici MG. Protein S-100B – a prognostic marker for cerebral damage. Curr Med Chem. 2006;13:3053–3060. doi: 10.2174/092986706778521751.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit